Foss, K.S.; O’Daniel, J.M.; Berg, J.S.; Powell, S.N.; Cadigan, R.J.; Kuczynski, K.J.; Milko, L.V.; Saylor, K.W.; Roberts, M.; Weck, K.;
et al. The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation. J. Pers. Med. 2022, 12, 692.
https://doi.org/10.3390/jpm12050692
AMA Style
Foss KS, O’Daniel JM, Berg JS, Powell SN, Cadigan RJ, Kuczynski KJ, Milko LV, Saylor KW, Roberts M, Weck K,
et al. The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation. Journal of Personalized Medicine. 2022; 12(5):692.
https://doi.org/10.3390/jpm12050692
Chicago/Turabian Style
Foss, Kimberly S., Julianne M. O’Daniel, Jonathan S. Berg, Sabrina N. Powell, Rosemary Jean Cadigan, Kristine J. Kuczynski, Laura V. Milko, Katherine W. Saylor, Megan Roberts, Karen Weck,
and et al. 2022. "The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation" Journal of Personalized Medicine 12, no. 5: 692.
https://doi.org/10.3390/jpm12050692
APA Style
Foss, K. S., O’Daniel, J. M., Berg, J. S., Powell, S. N., Cadigan, R. J., Kuczynski, K. J., Milko, L. V., Saylor, K. W., Roberts, M., Weck, K., & Henderson, G. E.
(2022). The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation. Journal of Personalized Medicine, 12(5), 692.
https://doi.org/10.3390/jpm12050692